MentionFox
Home › funding signals › DSIpharma, Inc.
Company · SEC filings

DSIpharma, Inc. funding history

Before you sign with, sell to or invest in DSIpharma, Inc.

MentionFox check on DSIpharma, Inc.: only 2 sources on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/company/dsipharma-inc

Check DSIpharma, Inc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about DSIpharma, Inc.?

Based on the records MentionFox holds for this company. No flag is not a clearance.

DSIpharma, Inc. has 2 Form D filings on record, from 2025-07-15 to 2026-10-02. Together its new offerings report $45K sold.

Is this your company?

Funding historyFounders and team

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

DSIpharma, Inc.: Raised $951K, Form D filed 2026-10-02
Share on LinkedIn Share on X Download image

Keep reading

More on this company and the records around it.

this company elsewhere on the record

What do you want to do with DSIpharma, Inc.?

Is DSIpharma, Inc. a real, registered company?

DSIpharma, Inc. is a registered filer with the SEC (CIK 2076369) and has filed since 2025-07-15. 2 filings are on record, the latest on 2026-10-02.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs DSIpharma, Inc.?

DSIpharma, Inc.'s filings name Kysha Pierre-Louis and Mark Ridall as its officers, directors or promoters.

How much has DSIpharma, Inc. raised?

Its new offerings report $45K sold across 1 offering, as its own filings state.

Run the free check on DSIpharma, Inc. →

Based
WILMINGTON, DELAWARE
Year formed
2025
Industry group
Other Health Care
Filings
2
Raised (new offerings)
$45K

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-10-02Amendment
first sale 2025-06-17
$951K$3Mdetails · SEC filing
2025-07-15New offering
first sale 2025-06-17
$45K$500Kdetails · SEC filing

Want the whole picture on DSIpharma, Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on DSIpharma, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on DSIpharma, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from DSIpharma, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Filings & events

Fundraising filings

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for DSIpharma, Inc.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/company/dsipharma-inc
Last updated 2026-11-04
Primary record: SEC filing 1 · SEC filing 2
How much has DSIpharma, Inc. raised? $45K in 2 SEC filings. MentionFox, 2026-11-04. https://mentionfox.com/company/dsipharma-inc